Page last updated: 2024-08-24

3-n-butylphthalide and Intracranial Arteriosclerosis

3-n-butylphthalide has been researched along with Intracranial Arteriosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, D; Li, B; Li, W; Shi, J; Wang, K; Yang, F; Yin, Y; Zhao, F1

Trials

1 trial(s) available for 3-n-butylphthalide and Intracranial Arteriosclerosis

ArticleYear
DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study.
    BMC neurology, 2020, May-26, Volume: 20, Issue:1

    Topics: Benzofurans; Double-Blind Method; Humans; Intracranial Arteriosclerosis; Neuroprotective Agents

2020
chemdatabank.com